Carbamic Acid

Carbamic Acid

SCHEMBL27675445

NC(=O)O.O=S(=O)(c1ccc(Oc2ccc(Cl)cc2)cc1)N1CCc2ccccc2C1

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 6/20 0.61
MEN1 O00255 3/20 0.60
KMT2A Q03164 3/20 0.60
MMP8 P22894 2/20 0.55
MMP3 P08254 1/20 0.55
SMN1; SMN2 Q16637 3/20 0.55
MAPT P10636 3/20 0.55
KDM4E B2RXH2 1/20 0.55
ALDH1A1 P00352 1/20 0.55
GAA P10253 1/20 0.53
AKR1C1 Q04828 2/20 0.52
ESR2 Q92731 1/20 0.52
CYP3A4 P08684 1/20 0.52
CYP2C19 P33261 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52
TSHR P16473 1/20 0.51
TP53 P04637 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Carbamic Acid SCHEMBL27675440 0.90 AKR1C3 (0.62) AKR1C3MEN1KMT2ASMN1; SMN2MAPT
Carbamic Acid SCHEMBL27693832 0.89 KMT2A (0.73) AKR1C3MEN1KMT2ASMN1; SMN2MAPT
Carbamic Acid SCHEMBL4693159 0.86 AKR1C3 (0.58) AKR1C3MEN1KMT2ASMN1; SMN2MAPT
Carbamic Acid SCHEMBL28763111 0.86 LMNA (0.59) AKR1C3MEN1KMT2ASMN1; SMN2MAPT
SCHEMBL5915341 0.85 KMT2A (0.77) AKR1C3MEN1KMT2ASMN1; SMN2MAPT
Carbamic Acid SCHEMBL27675490 0.79 SMN1; SMN2 (0.54) AKR1C3MEN1KMT2ASMN1; SMN2MAPT
SCHEMBL23081190 0.78 AKR1C3 (0.78) AKR1C3MEN1KMT2ASMN1; SMN2MAPT
SCHEMBL693455 0.77 KMT2A (1.00) AKR1C3MEN1KMT2ASMN1; SMN2MAPT
Carbamic Acid SCHEMBL27675461 0.77 MAPT (0.43) MEN1KMT2AMMP8MMP3SMN1; SMN2
SCHEMBL20389408 0.75 KMT2A (0.77) AKR1C3MEN1KMT2ASMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101006059-A Substituted tetrahydroisoquinolines for use as MMP inhibitors, method for the production thereof, and use thereof in the form of medicaments SANOFI AVENTIS DEUTSCHLAND (DE) 2007-07-25 CN disclosed